nicholas moore
Université de Bordeaux
H-index: 77
Europe-France
Top articles of nicholas moore
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the … | Cardiovascular Diabetology | Patrick Blin Michael Joubert Patrick Jourdain Philippe Zaoui Estelle Guiard | 2024/1/9 |
Quince extract resists atherosclerosis in rats by down-regulating the EGFR/PI3K/Akt/GSK-3β pathway | Biomedicine & Pharmacotherapy | Abulaiti Abulizi Jimilihan Simayi Maimaitiming Nuermaimaiti Mengyuan Han Sendaer Hailati | 2023/4/1 |
Cardiovascular or renal disease (CVRD) complication and mortality incidence for type 2 diabetics with a single or without CVRD comorbidity: A 5-year SNDS nationwide claims … | Archives of Cardiovascular Diseases Supplements | P Jourdain P Blin P Zaoui E Guiard D Sakr | 2023/1/1 |
Long-Term, Comparative Safety Study of People with Multiple Sclerosis Newly Started on Cladribine Tablets (CLARION): Study Status Update and Representativeness | Multiple Sclerosis and Related Disorders | Tjalf Ziemssen Stig Wergeland Helmut Butzkueven Melinda Magyari Jan Hillert | 2023/12/1 |
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis | Current Medical Research and Opinion | Helmut Butzkueven Jan Hillert Merja Soilu-Hänninen Tjalf Ziemssen Jens Kuhle | 2023/10/3 |
Do Different Sutures with Triclosan Have Different Antimicrobial Activities? A Pharmacodynamic Approach | Antibiotics | Frederic C Daoud Fatima M’Zali Arnaud Zabala Nicholas Moore Anne-Marie Rogues | 2022/9/3 |
Do triclosan sutures modify the microbial diversity of surgical site infections? a systematic review and meta-analysis | Frederic C Daoud Maïder Coppry Nicholas Moore Anne-Marie Rogues | 2022/4/28 | |
Use of real‐world evidence in translational pharmacology research | Mathieu Charvériat Stephan J Darmoni Vincent Lafon Nicholas Moore Régis Bordet | 2022/4 | |
Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database | Nicolas H Thurin Magali Rouyer Jérémy Jové Marine Gross-Goupil Thibaud Haaser | 2022/9/2 | |
How Long Do Implanted Triclosan Sutures Inhibit Staphylococcus aureus in Surgical Conditions? A Pharmacological Model | Pharmaceutics | Frederic Christopher Daoud Ruben Goncalves Nicholas Moore | 2022/2/28 |
Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-Analysis | Frederic C Daoud Louis Létinier Nicholas Moore Pierre Coste Pasi P Karjalainen | 2022/12/7 | |
Cumulative cardiovascular or renal disease (CVRD) hospital costs for type 2 diabetics free of CVRD at baseline: a 5-year cohort study in the SNDS nationwide claims database | P Zaoui M Joubert F Thomas-Delecourt S Bineau N Moore | 2022/9/1 | |
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users … | American journal of cardiovascular drugs: drugs, devices, and other interventions | Patrick Blin Caroline Dureau-Pournin Jacques Bénichou Yves Cottin Patrick Mismetti | 2022/1 |
First occurred cardiovascular or renal disease (CVRD) cumulative incidence for type 2 diabetics free of CVRD at baseline: a 5-year SNDS nationwide claims database cohort study | P Blin M Joubert P Zaoui E Guiard D Sark | 2022/9/1 | |
EE600 Cumulative Cardiovascular or Renal Disease (CVRD) Hospital Costs for Type 2 Diabetics Free of CVRD at Baseline: A 5-Year Cohort Study in the SNDS Nationwide Claims Database | Value in Health | P Blin P Zaoui M Joubert E Guiard D Sakr | 2022/12/1 |
The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly … | Current Medical Research and Opinion | Helmut Butzkueven Nicholas Moore Aida Aydemir Jaak Sõnajalg Irene Bezemer | 2022/7/3 |
Should dual antiplatelet therapy be maintained beyond one year after a myocardial infarction? A cohort study within the French SNDS nationwide claims database | European Heart Journal | P Blin N Danchin J Benichou C Dureau-Pournin E Guiard | 2022/10/1 |
Adherence to direct oral anticoagulants in patients with non-valvular atrial fibrillation: A cross-national comparison in Six European Countries (2008–2015) | Frontiers in pharmacology | M Sabaté X Vidal E Ballarin S Schmiedl C Gasse | 2021/11/3 |
ORIGINAL INVESTIGATION | Irineu Loturco Timothy Suchomel Chris Bishop Ronaldo Kobal Lucas A Pereira | 2018 | |
Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban—A European comparative drug utilization study | Basic & Clinical Pharmacology & Toxicology | Marietta Rottenkolber Sven Schmiedl Luisa Ibánez Mònica Sabaté Elena Ballarín | 2021/3 |
